Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Stereoselective Glycosylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115925756B details a high-stereoselective TN antigen preparation method avoiding noble metals, offering cost reduction and supply chain reliability for vaccine developers.
Patent CN113234113A details organic catalysis for 1,2-cis-glycosidic bonds. Enhances supply chain reliability and cost efficiency for vaccine antigen manufacturing.
Novel cis-double bond α-glycosylceramide isomer synthesis patent offers high stereoselectivity and cost-effective manufacturing for immunotherapy intermediates.
Patent CN101628927A details a stereoselective route for Gemcitabine. Discover cost reduction in pharmaceutical manufacturing and high-purity oncology intermediates.
Patent CN101801382B reveals a scalable route for DAPD using alpha-cyano additives, offering high stereoselectivity and cost-effective API manufacturing solutions.
Patent CN111471077B reveals a novel 2-deoxy-D-ribose derivative route achieving 8:1 beta-selectivity. Discover cost-effective, scalable manufacturing for oncology APIs.
Patent CN103087132A reveals oxidizing agent method for beta-nucleosides. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN111377989B reveals a high-selectivity synthesis for decitabine intermediates, offering superior beta-isomer ratios and scalable purification for cost-effective API manufacturing.
Patent CN103539827B details high-yield thiooligosaccharide synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel two-step stereocontrolled synthesis of ADP-ribose polypeptides from NAD. Reduces purification complexity and enables scalable production for drug discovery.
Novel scalable route for antisense oligonucleotide intermediates ensuring high purity and cost reduction without preparative chromatography.
Novel chiral auxiliary method for Lamivudine production offering superior stereocontrol and simplified purification for reliable pharmaceutical intermediate supply chains.
Patent CN101307048A details a novel stereoselective method for Lamivudine using chiral auxiliaries, offering superior purity and cost-effective manufacturing for global supply chains.
Patent CN106046089A reveals a cobalt-catalyzed route for Decitabine. Achieves high beta-selectivity and purity for reliable pharmaceutical intermediate supply chains.
Patent CN1172945C details a streamlined 3-step synthesis of etoposide from glucose. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN101381387A reveals a cost-effective, stereoselective route for Gemcitabine Hydrochloride, eliminating cryogenic conditions and improving supply chain reliability for API manufacturers.
Patent CN104926806B reveals a robust method for Lamivudine intermediates, offering high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN1989148A reveals a solid-state synthesis route for 1-alpha-halo-2,2-difluoro-2-deoxy-D-ribofuranose, enabling scalable Gemcitabine production with superior purity.
Patent CN114163483A discloses a novel PTFAI-mediated alpha-glycosylation method offering high stereoselectivity and mild conditions for reliable pharmaceutical intermediate supply.
Patent CN109111490B introduces a novel halogenated pivaloyl glucopyranose route for SGLT2 inhibitors, offering superior stereoselectivity and industrial scalability for pharmaceutical manufacturing.